Dimensional Fund Advisors’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $481K | Sell |
120,145
-131,939
| -52% | -$528K | ﹤0.01% | 3001 |
|
|
2025
Q1 | $229K | Sell |
252,084
-252,586
| -50% | -$230K | ﹤0.01% | 3110 |
|
|
2024
Q4 | $1.4M | Buy |
504,670
+58,518
| +13% | +$162K | ﹤0.01% | 2864 |
|
|
2024
Q3 | $2.33M | Buy |
446,152
+66,088
| +17% | +$346K | ﹤0.01% | 2752 |
|
|
2024
Q2 | $1.7M | Buy |
380,064
+205,417
| +118% | +$916K | ﹤0.01% | 2800 |
|
|
2024
Q1 | $1.34M | Buy |
174,647
+110,962
| +174% | +$850K | ﹤0.01% | 2869 |
|
|
2023
Q4 | $272K | Buy |
63,685
+4,244
| +7% | +$18.1K | ﹤0.01% | 3148 |
|
|
2023
Q3 | $250K | Sell |
59,441
-23,755
| -29% | -$99.8K | ﹤0.01% | 3179 |
|
|
2023
Q2 | $463K | Buy |
83,196
+32,619
| +64% | +$182K | ﹤0.01% | 3079 |
|
|
2023
Q1 | $287K | Buy |
50,577
+28,370
| +128% | +$161K | ﹤0.01% | 3132 |
|
|
2022
Q4 | $24 | Sell |
22,207
-4,836
| -18% | -$5 | ﹤0.01% | 3447 |
|
|
2022
Q3 | $73K | Buy |
27,043
+13,956
| +107% | +$37.7K | ﹤0.01% | 3368 |
|
|
2022
Q2 | $63K | Buy |
+13,087
| New | +$63K | ﹤0.01% | 3375 |
|